Offer for Sale: The objects of the Offer are to achieve the benefits of listing on the Stock Exchanges and for the sale of Equity Shares by the Selling Shareholders. Further, Company expects that the listing of the Equity Shares will enhance their visibility and brand image among their existing and potential clients and provide liquidity to the existing shareholders. Company will not receive any proceeds from the Offer for Sale and all the proceeds will go to the Selling Shareholders....
Strong growth in AUM with focus shifting towards retail loans: CFL has witnessed AUM growth of ~25/44/66% CAGR over the last 3/4/5 years driven by strong growth in retail assets portfolio. In line with the company strategy of focusing on MSME and Retail loans the wholesale loan book has largely remained more or less flat over the last 4-5 years at ~Rs 2000 cr while the MSME and retail loan book has grown at CAGR of 43% over FY12-FY15. We expect the company to maintain its growth rate of ~25% over FY15-FY17. The management has guided for an AUM of Rs 28000 30000 cr by FY19 which implies CAGR of ~23-25%. Rigorous credit underwriting process to maintain asset quality:...
Tapping new categories and expanding geographical reach: After establishing a strong foothold in the cotton bed sheets segment Indo Count is looking to tap into the larger bed sheet categories Fashion Bedding, Utility Bedding and Institutional Bedding. These categories are high margin business and would expand the target market for Indo Count from $4.5 bn to $14 bn. These categories currently account for 5% of the Home Textile segment's revenues and the management targets to increase it to 25% by FY18E. Most of the home textile designs and printing are developed in-house and are patent protected. These product differentiations, innovations, patents and experience will aid to gain market share. ICIL is also...
Government thrust on renewable energy: Development of renewable energy is imperative for the energy security of our import dependant nation. As a result the Government has increased the target of renewable energy to 175 GW (60 GW wind) by 2022. It is also providing various incentives to increase investments in renewable energy like accelerated depreciation, generation based incentives of Re 0.5/unit, allowing wind power as a Corporate Social Responsibility activity, duty exemption on raw materials, etc. RBI has also notified loans of upto Rs 15 cr for installation of wind mills to be classified as priority sector lending. All these measures would result in higher investment...
The global bearings market grew 4% in CY14 reaching total size of USD 40 billion. The industrial original equipment bearing markets accounted for ~40% of world demand and included manufacturers of light and heavy industrial machines and equipment, as well as aerospace, off-highway and railway vehicles. Sales through distributors (industrial distribution and the independent vehicle aftermarket) maintained around 30% of world bearing demand, of which around 30% is related to the vehicle service market and around 70% to the industrial market. The automotive original equipment bearing markets, including two and four-wheelers, accounted for ~30%....
collected and processed approximately 21.8 million samples from Dr Lal Path Lab serves approximately 9.9 million patients. According to CRISIL Research, the size of the Indian diagnostic healthcare services industry was approximately Rs.377 billion (US$6.0 billion) in Fiscal Year 2015, and it is projected to grow to over Rs.600 billion (US$9.6 billion) by Fiscal Year 2018. We believe that the increasing prescription of diagnostic tests and services by healthcare providers in India, combined with the growing focus on early detection and prevention of chronic and lifestyle diseases, such as diabetes, hypertension, heart disease and cancer, creates a significant market...
internationally, primarily the United States. With a wide ranging Alkem Laboratories Ltd. (ALL) is present across acute and chronic therapeutic segments with substantial brand share in the Anti-infective, Gastro-intestinal, Pain Management, Vitamins / Minerals / Nutritions, Central Nervous System, Anti-diabetic, Anti-osteoporosis, Anti-malarial, Cardiovascular, Immunosuppressant, and Nutraceutical segments. ALL has developed a portfolio of 736 branded generic drugs and command market leadership, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015. ALL has 16 manufacturing facilities, 14 in India and 2 in US. 5 of facilities are US FDA,...
Note: *The Issue shall remain open for subscription during the period indicated above, with an option for early closure or extension, as may be decided by the Board of Directors or the Bond Committee. In the event of such early closure or extension of the subscription period of the Issue, our Company shall ensure that public notice of such early closure or extension is published on or before the day of such early date of closure or the Issue Closing Date, as the case may be, through advertisement/s in at least one leading national daily newspaper with wide circulation....
Since our first coverage of Force Motors Ltd. (FML) in February 2015, the stock has more than doubled, in just about 8 months. With all segments of its business poised for an uptick, trading at 23.1X its FY17E EPS, we believe it is strong long term investment idea. FML is automobile company with focus on designing, development and manufacturing of vehicles mainly LCV, UV's and tractors and auto components. FML enjoys the market leadership position of 61% share in the LCV passenger segment in India. Force also has technical collaboration with Daimler AG, Germany in respect of multi-purpose passenger vehicles. FML partnered with Indian arm of German luxury auto maker BMW in its strategy for...
PVR pioneered the multiplex revolution in India by establishing its first multiplex in 1997. Since then the company has spread its wings across 106 properties in 43 cities having 474 screens as of Aug-15. It acquired Cinemax in 2012 to become the largest multiplex operator in the country. Low density of screens as compared to emerging and developed world and better movie watching experience provided by multiplexes is leading to a preference change among the public towards multiplexes. After a subdued FY15 we expect the company to grow its revenues/PAT by 27%/227% respectively over FY15-FY17 driven by higher footfalls, increased F&B; spend and greater focus on in-cinema ad revenues. We assign BUY rating for...
